DOCSLIB.ORG

List of Members and Other Participants

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Members and Other Participants LIST OF MEMBERS AND OTHER PARTICIPANTS MEMBERS, ALTERNATES AND ADVISERS SINGAPORE Dr B. SADASIVAN, Senior Minister of State for Foreign Affairs, Singapore (Chairman) Alternates Dr CHEW Suok Kai, Deputy Director of Medical Services, Ministry of Health, Singapore Mr TAN York Chor, Ambassador, Permanent Representative, Geneva Mr S.N. SYED HASSIM, Deputy Permanent Representative, Geneva Dr B. KOH, Assistant Director (Director of Medical Services’ Office and Risk Analysis), Ministry of Health, Singapore Mr C. WONG, Assistant Director (International Cooperation), Ministry of Health, Singapore Mr T.S. SADANADOM, Health Policy Analyst (International Cooperation), Ministry of Health, Singapore Ms F. GAN, First Secretary, Permanent Mission, Geneva AFGHANISTAN Dr H. AHMADZAI, Head, International Relations Department, Ministry of Public Health, Kabul Alternate Mr O.K. NOORI, First Secretary, Permanent Mission, Geneva AZERBAIJAN Professor O. SHIRALIYEV, Minister of Health, Baku Alternates Mr E. AMIRBAYOV, Ambassador, Permanent Representative, Geneva Dr S. ABDULLAYEV, Head, International Relations Department, Ministry of Health, Baku Dr S. SEVDIMALIYEVA, Head, Department of Endoscopy, Institute of Obstetrics and Gynaecology, Baku Mr R. NOVRUZOV, Third Secretary, Permanent Mission, Geneva BAHAMAS Dr M. DAHL-REGIS, Chief Medical Officer, Ministry of Health and Social Development, Nassau Alternate Ms S. SMITH, Health Planner, Ministry of Health and Social Development, Nassau BHUTAN Dr JIGMI SINGAY, Thimphu (Rapporteur) Alternates Mr S.T. RABGYE, Ambassador, Permanent Representative, Geneva - 1 - 2 EXECUTIVE BOARD, 122ND SESSION Dr G. TSHERING, Secretary, Ministry of Health, Thimphu Advisers Mr T. DORJI, Chief Planning Officer, Policy and Planning Division, Ministry of Health, Thimphu Ms D. TSHERING, Deputy Permanent Representative, Geneva Mr S. WANGCHUK, Counsellor, Permanent Mission, Geneva Mr P. NORBU, Second Secretary, Permanent Mission, Geneva CHINA Mr LI Baodong, Ambassador, Permanent Representative, Geneva Alternates Mr WANG Qun, Ambassador, Deputy Permanent Representative, Geneva Dr REN Minghui, Deputy Director-General, Department of International Cooperation, Ministry of Health, Beijing Advisers Dr YU Xiucheng, Deputy Director-General, Department of Medical Science Technology and Education, Ministry of Health, Beijing Mr LA Yifan, Counsellor, Permanent Mission, Geneva Ms DONG Zhihua, Counsellor, Permanent Mission, Geneva Dr XING Jun, Division Director, Department of International Cooperation, Ministry of Health, Beijing Mr YANG Xiaokun, Division Director, Department of International Organizations and Conferences, Ministry of Foreign Affairs, Beijing Dr LI Zhipeng, Deputy Division Director, Office of Health Emergency Response, Ministry of Health, Beijing Dr YANG Feng, Deputy Division Director, Bureau of Disease Prevention and Control, Ministry of Health, Beijing Mr XIAO Hong, Programme Officer, International Exchange and Cooperation Center, Ministry of Health, Beijing Mr XU Jingjing, Third Secretary, Department of International Organizations and Conferences, Ministry of Foreign Affairs, Beijing Mr ZHANG Ze, Third Secretary, Permanent Mission, Geneva Ms HAN Jixiu, Programme Officer, Department of International Cooperation, Ministry of Health, Beijing Ms WANG Dan, Attaché, Permanent Mission, Geneva DENMARK Mr J. FISKER, Director General, National Board of Health, Copenhagen Alternates Mrs M.-L. OVERVAD, Ambassador, Permanent Representative, Geneva Mr M. JØRGENSEN, Head of Division, Ministry of Health and Prevention, Copenhagen Dr E. SMITH, Director, National Board of Health, Copenhagen Advisers Ms M. KRISTENSEN, Senior Adviser, National Board of Health, Copenhagen Dr S.J. JØRGENSEN, Senior Adviser, National Board of Health, Copenhagen Ms H.E. KRARUP, Head of Section, Ministry of Health and Prevention, Copenhagen Mr A. BERLING-RASMUSSEN, First Secretary, Permanent Mission, Geneva Ms I.W. RASMUSSEN, Permanent Mission, Geneva MEMBERS AND OTHER PARTICIPANTS 3 DJIBOUTI M. A.A. MIGUIL, Ministre de la Santé, Djibouti (Vice-Chairman) Alternates Dr K.I. OUSMAN, Conseiller technique, Ministère de la Santé, Djibouti Mme S.I. MAHAMOUD, Chef, Service de l’Education pour la Santé, Ministère de la Santé, Djibouti M. A.M. ABRO, Premier Conseiller, Mission permanente, Genève EL SALVADOR Dr. J.G. MAZA BRIZUELA, Ministro de Salud, Pública y Asistencia Social, San Salvador (Vice-Chairman) Alternates Dr. B.F. LARIOS LÓPEZ, Embajador, Representante Permanente, Ginebra Dr. H. ALCIDES URBINA, Director General de Salud, Ministerio de Salud, Pública y Asistencia Social, San Salvador Sra. L. ALVARADO DE OVERDIEK, Consejera, Misión Permanente, Ginebra INDONESIA Dr S.F. SUPARI, Minister of Health, Jakarta Alternate Dr I.N. KANDUN, Director General for Diseases Control and Environmental Health, Ministry of Health, Jakarta Advisers Dr W. LUKITO, Adviser to the Minister of Health, Ministry of Health, Jakarta Mr I.G.A.W. PUJA, Ambassador, Deputy Permanent Representative and Chargé d’Affaires a.i., Geneva Dr BUDIHARDJA, Head, Centre for Planning, Ministry of Health, Jakarta Ms L.S.W. SULISTYOWATI, Head, Centre for Public Communication, Ministry of Health, Jakarta Ms M. UTAMI, Head of Protocol, Ministry of Health, Jakarta Mr A. SOMANTRI, First Secretary, Permanent Mission, Geneva Ms I.N. SAVITRI, Third Secretary, Permanent Mission, Geneva Dr WIDIYARTI, Deputy Head, Center for Bilateral and Regional Cooperation, Jakarta Mr B. SURYOWIBOWO, Protocol Staff, Ministry of Health, Jakarta IRAQ Dr S.M.M. AL-HASNAWI, Minister of Health, Baghdad Alternates Mr B. AL-SHIBIB, Ambassador, Permanent Representative, Geneva Dr A.K. IBRAHIM, Office of the Minister of Health, Ministry of Health, Baghdad Mr G.F. AL-ANBAKI, First Secretary, Permanent Mission, Geneva Mrs B. FADHLI, Third Secretary, Permanent Mission, Geneva 4 EXECUTIVE BOARD, 122ND SESSION JAPAN Dr H. SHINOZAKI, President, National Institute of Public Health, Tokyo Alternates Mr I. FUJISAKI, Ambassador Extraordinary and Plenipotentiary, Permanent Representative, Geneva Mr H. MINAMI, Minister, Permanent Mission, Geneva Mr H. NONO, Assistant Director-General for International Affairs, Minister’s Secretariat, Ministry of Health and Welfare, Tokyo Mr N. TAGAYA, Counsellor, Permanent Mission, Geneva Dr H. INOUE, Director, International Cooperation Office, International Affairs Division, Minister’s Secretariat, Ministry of Health and Welfare, Tokyo Mr K. NATSUME, First Secretary, Permanent Mission, Geneva Dr M. SUMI, Deputy Director, International Affairs Division, Minister’s Secretariat, Ministry of Health and Welfare, Tokyo Dr Y. SUGIURA, Deputy Director, International Affairs Division, Minister’s Secretariat, Ministry of Health and Welfare, Tokyo Mr D. HOSHINO, Deputy Director, Specialized Agencies Division, International Cooperation Bureau, Ministry of Foreign Affairs, Tokyo LATVIA Dr V. JAKSONS, Adviser to the State Secretary on International Affairs, Ministry of Health, Riga (Vice-Chairman) Alternates Mr J. MAŽEIKS, Ambassador Extraordinary and Plenipotentiary, Permanent Representative, Geneva Mrs I. DREIMANE, First Secretary, Permanent Mission, Geneva LIBERIA Dr W.T. GWENIGALE, Minister of Health and Social Welfare, Monrovia (Vice-Chairman) Alternate Mrs J. EBBA-DUNCAN, Assistant Minister for Preventive Services, Ministry of Health and Social Welfare, Monrovia MADAGASCAR Dr R.R. JEAN LOUIS, Ministre de la Santé, du Planning familial et de la Protection sociale, Antananarivo Alternates M. A. RAMBELOSON, Ambassadeur, Représentant permanent, Genève M. J.-P. RAKOTONIRINA, Ministre Conseiller, Mission permanente, Genève MEMBERS AND OTHER PARTICIPANTS 5 MALAWI Professor F. SALANIPONI, Director, National TB Control Programme, Ministry of Health, Lilongwe Alternates Dr K. KAMOTO, Head, HIV/AIDS Unit, Ministry of Health, Lilongwe Dr S. KABULUZI, Deputy Director, Preventive Health Services, Ministry of Health, Lilongwe MALI M. O.I. TOURÉ, Ministre de la Santé, Bamako Alternates M. S.L. SOW, Ambassadeur, Représentant permanent, Genève Dr O.S. DJAKITÉ-MAÏGA, Conseiller technique, Ministère de la Santé, Bamako Professeur T. SIDIBE, Directeur national de la Santé, Bamako Dr S. SAMAKE, Directeur de la Planification, Ministère de la Santé, Bamako Mr S. KASSE, Premier Conseiller, Mission permanente, Genève Mr A. MAÏGA, Deuxième Conseiller, Mission permanente, Genève MEXICO Dr. M. HERNÁNDEZ ÁVILA, Subsecretario de Prevención y Promoción de la Salud, Secretaría de Salud, México, DF Alternates Dr. J.A. CÓRDOVA VILLALOBOS, Secretario de Salud, México, DF Sra. M. GÓMEZ OLIVER, Embajadora, Representante Permanente Alterna, Ginebra Dra. M.A. FROMOW, Titular de la Unidad Coordinadora de Vinculación y Participación Social, Secretaría de Salud, México, DF Sr. F. HERNÁNDEZ AGUILAR, Director General de Relaciones Internationales, Secretaría de Salud, México, DF Sra. A. VELÁZQUEZ BERUMEN, Directora General, Centro Nacional de Excelencia Tecnológica en Salud, Secretaría de Salud, México, DF Dr. F. MENESES GONZÁLEZ, Asesor del Subsecretario de Prevención y Promoción de la Salud, Secretaría de Salud, México, DF Sra. D.M. VALLE ÁLVAREZ, Consejero, Misión Permanente, Ginebra Sr. S. TINAJERO, Tercer Secretario, Misión Permanente, Ginebra Sra. H. ARRINGTON AVIÑA, Subdirectora para Organismos Multilaterales, Secretaría de Salud, México, DF NAMIBIA Dr N. FORSTER, Deputy Permanent Secretary, Ministry of Health and Social Services, Windhoek (alternate to Mr K. Kahuure) Alternate Ms D. TJIPURA, Director, Tertiary Health Care and Clinical Support Services, Ministry
Load more

Recommended publications
  • From the Factory to the Frontlines the Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine
    From the Factory to the Frontlines The Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine What This Strategy Aims to Do This report to Congress details a strategy to achieve the principal purpose and objective of Operation Warp Speed (OWS): ensuring that every American who wants to receive a COVID-19 vaccine can receive one, by delivering safe and effective vaccine doses to the American people beginning January 2021. The leadership of OWS has committed to being transparent with Congress, the media, and the American people. OWS has provided regular briefings on topics of interest to Congress and the media and will continue to provide updates and announcements as OWS reaches new milestones. Congress has been a vital partner in the all-of-America response to the COVID-19 pandemic. With support provided through emergency supplemental and flexible discretionary funding, OWS has now made strong progress toward a safe and effective COVID-19 vaccine, with multiple candidates in Phase 3 clinical trials. Simultaneously, OWS and partners are developing a plan for delivering a safe and effective product to Americans as quickly and reliably as possible. Experts from the Department of Health and Human Services (HHS) are leading vaccine development, while experts from the Department of Defense (DoD) are partnering with the Centers for Disease Control and Prevention (CDC) and other parts of HHS to coordinate supply, production, and distribution of vaccines. Successful implementation of the national COVID-19 vaccination program requires precise coordination across federal, state, local, tribal, and territorial governments and among many public and private partners.
    [Show full text]
  • List of Eligible Applicants and Estimated Funding Award Amounts by Category
    Attachm nt A OOOTTT222111 ––– 222111 333::: NNNatatatiiiooonnnalalal IIInnniiitttiiiatatatiiivvveee tttooo AAAddddddrrreeessssss CCCOOOVVVIIIDDD---111999 HHHeeealalalttthhh DDDiiissspppararariiitttiiieeesss amamamooonnnggg PPPooopppuuulllatatatiiiooonnnsss atatat HHHiiiggghhh---RRRiiissskkk anananddd UUUnnndddeeerrrssseeerrrvvveeeddd,,, IIInnncccllluuudddiiinnnggg RRRacacaciiialalal anananddd EEEttthhhnnniiiccc MMMiiinnnooorrriiitttyyy PPPooopppuuulllatatatiiiooonnnsss anananddd RRRuuurrralalal CCCooommmmmmuuunnniiitttiiieeesss List of Eligible Applicants and Estimated Funding Award Amounts by Category State Estimated Awards Award ange $17,000,000 - $50,000,000 Award Average $32,000,000 Eligible Applicants Alabama D partm nt of Public H alth (ADPH) Alaska D partm nt of H alth and Social S rvic s - Division of Public H alth Arizona D partm nt of H alth S rvic s Arkansas D partm nt of H alth California D partm nt of Public H alth Colorado D partm nt of Public H alth and Environm nt Conn cticut D partm nt of Public H alth D lawar D partm nt of H alth and Social S rvic s- Division of Public H alth Florida D partm nt of H alth G orgia D partm nt of Public H alth Hawaii Stat D partm nt of H alth Idaho D partm nt of H alth and W lfar Illinois D partm nt of Public H alth Indiana D partm nt of H alth Iowa D partm nt of Public H alth Kansas D partm nt of H alth & Environm nt K ntucky D partm nt for Public H alth Louisiana D partm nt of H alth Main D partm nt of H alth and Human S rvic s Maryland D partm nt of H alth Massachus tts D partm nt of Public
    [Show full text]
  • 2011 State Profile — Palau
    2011 State Profile — Palau National Survey of Substance Abuse Treatment Services (N-SSATS) The National Survey of Substance Abuse Treatment Services (N-SSATS) is an annual survey of facilities providing substance abuse treatment. It is conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA). N-SSATS is designed to collect data on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) throughout the 50 States, the District of Columbia, and other U.S. jurisdictions. More information on N-SSATS methodology is available at the following URL: http://www.samhsa.gov/data/2k3/NSSATS/NSSATS.pdf In Palau, 1 substance abuse treatment facility was included in the 2011 N-SSATS, reporting that there were 105 clients in substance abuse treatment on March 31, 2011. The survey response rate in Palau was 100.0%. Facility Operation Clients in Treatment on March 31, 2011 Facilities All Clients Clients Under Age 18 No. % No. % No. % Private non-profit 0 0.0 0 0.0 0 0.0 Private for-profit 0 0.0 0 0.0 0 0.0 Local, county, or community government 1 100.0 105 100.0 10 100.0 State government 0 0.0 0 0.0 0 0.0 Federal government 0 0.0 0 0.0 0 0.0 Dept. of Veterans Affairs 0 0.0 0 0.0 0 0.0 Dept. of Defense 0 0.0 0 0.0 0 0.0 Indian Health Service 0 0.0 0 0.0 0 0.0 Other 0 0.0 0 0.0 0 0.0 Tribal government 0 0.0 0 0.0 0 0.0 Total 1 100.0 105 100.0 10 100.0 Primary Focus of Facility Clients in Treatment on March 31, 2011 Facilities All Clients Clients Under Age 18 No.
    [Show full text]
  • Deputy Health Officer
    County of Monterey 14K54 DEPUTY HEALTH OFFICER DEFINITION Under general direction of the Health Officer, assists the Health Officer in the administration and medical oversight of public health programs for the County; provides health policy consultation on health and preventative medicine issues to the Health Officer, department staff, citizens, public officials, community organizations, agencies and staff; in the absence of the Health Officer, serves as the designated County Health Officer; and performs other related work as required DISTINGUISHING CHARACTERISTICS This single position management level class is responsible to the Health Officer for assisting in providing medical oversight, consultation and/or enforcement of public health regulations for a variety of public health programs and services, including environmental health, vital records, communicable disease control, preventative chronic and acute general medical services, public health nursing, emergency and disaster medical planning, public health education, California Children’s Service, and maternal and child health services. This position provides principal supervision of Vital Records, Health Assessment, Laboratory, and Epidemiology programs. This position is distinguished from the Health Officer in that the Health Officer is appointed by the County Board of Supervisors, directs medical oversight and policy for the County, and possesses the powers, duties, and responsibilities relating to the preservation and protection of public health. The Deputy Health Officer assists in directing the medical oversight and policy for the County, and does not carry full powers, duties and responsibilities relating to public health, but may act in the absence of the Health Officer. The Deputy Health Officer is distinguished from lower level management or physician classes in that the latter directs specific areas of program responsibility or medical practice, whereas the Deputy Health Officer assists in directing the medical oversight for all public health programs EXAMPLES OF DUTIES 1.
    [Show full text]
  • Clinical Audit/Quality Improvement Projects Guidance for Professional
    Clinical Audit/Quality Improvement Projects Guidance For Professional Competence Scheme Prepared by Faculty of Public Health Medicine December 2012 1 KEY POINTS ON AUDIT FOR PUBLIC HEALTH . This document is produced by the Faculty of Public Health Medicine Ireland (FPHMI) to support and guide participants of the FPHMI Professional Competence Scheme (PCS) to achieve their requirement of completing one clinical audit / quality improvement project each year. This document is a guide for doctors practising public health medicine and who are either on the Specialist or General Division of the Register . All doctors must participate in professional competence . Each doctor must define his/her scope of practice . All doctors whose practice include both clinical and non‐clinical work should engage in both clinical audit and other quality improvement practices relevant to their scope of practice . Audit can be at individual, team, departmental or national level . Each doctor must actively engage in clinical audit / systematic quality improvement activity that relates directly to their practice. ‘The Medical Council’s Framework for Maintenance of Professional Competence Activities’ sets one clinical audit per year as the minimum target. The time spent on completing the audit is accounted for separately from other Continuing Professional Development (CPD) activities. It is estimated that the completion of one clinical audit will take approximately 12 hours of activity. The main challenges in undertaking audit in public health practice include o Lack of explicit criteria against which to measure audit o Timeframes for measuring outcomes which can be prolonged and thus process measures are more readily measured Can’t seem to format this box which is smaller than the text o Changing public health work programmes in Departments .
    [Show full text]
  • The High Achieving Governmental Health Department in 2020 As the Community Chief Health Strategist
    The High Achieving Governmental Health Department in 2020 as the Community Chief Health Strategist Public Health Leadership Forum This paper was prepared by RESOLVE as part of the Public Health Leadership Forum with funding from the Robert Wood Johnson Foundation. John Auerbach, Director of Northeastern University’s Institute on Urban Health Research, also put substantial time and effort into authoring the document with our staff. The concepts put forth are based on several working group session (See Appendix B for members) and are not attributable to any one participant or his/her organization. May 2014 The High Achieving Governmental Health Department in 2020 as the Community Chief Health Strategist Public Health Leadership Forum Background Local and state health departments need to adapt and evolve if governmental public health is to address emerging health demands, minimize current as well as looming pitfalls, and take advantage of new and promising opportunities. To succeed requires a view into the future. This paper provides that vision. And, importantly, it zeroes in on what a high achieving public health department of the future will be doing differently. It does so not with a comprehensive inventory of tasks but rather with a distillation of the most important new skills and activities essential to be high achieving and serve in the role of the community chief health strategist. A working group of public health practitioners and policy experts was convened by RESOLVE as part of the Public Health Leadership Forum with funding from the Robert Wood Johnson Foundation (See Appendix B for a list of members). The working group purposely set a time frame of public health in 2020 – just six years into the future – in order to look far enough ahead to provide a compelling beacon, while staying close enough to the present to emphasize the urgency of taking immediate steps to start the process of change and build the leadership necessary to be successful.
    [Show full text]
  • VDH (VBDPH) Mandated Services
    VIRGINIA DEPARTMENT OF HEALTH (VDH) SUMMARY OF MANDATES REQUIRED BY FEDERAL LAW, STATE LAW, CONTRACT OR INTERAGENCY AGREEMENT Revised for Virginia Beach Department of Public Health March 2017 Note: The majority of Public Health Laws in the State of Virginia are found in Title 32 in the State Legislative Information System. Specific chapters of the law are referenced in the table below. 1. OVERARCHING AGENCY MISSION, CONTEXT AND STRUCTURE Mandated Service or Authority (and Obligating Description of Mandate or Authorizing Text Activity Instrument, if any): Establishment of the §§ 32.1-2, 32.1-16 There shall be a State Board of Health and a State Department of State Board of Health Health in the executive department responsible to the Secretary of and the State Health and Human Resources. Department of Health Purpose of the Board §32.1-2 The General Assembly finds that the protection, improvement and and Department preservation of the public health and of the environment are essential to the general welfare of the citizens of the Commonwealth. For this reason, the State Board of Health and the State Health Commissioner, assisted by the State Department of Health, shall administer and provide a comprehensive program of preventive, curative, restorative and environmental health services, educate the citizenry in health and environmental matters, develop and implement health resource plans, collect and preserve vital records and health statistics, assist in research, and abate hazards and nuisances to the health and to the environment, both emergency and otherwise, thereby improving the quality of life in the Commonwealth. Development of §32.1-11 The Board may formulate a program of environmental health, Programs laboratory services, and preventive, curative and restorative medical care services, including home and clinic health services.
    [Show full text]
  • Final Task Force Report 2015 6-29 2
    June 2015 Task Force on Behavioral Health Data Policies and Long Term Stays Final Report to the Health Policy Commission, the Joint Committee on Mental Health and Substance Abuse, and the Joint Committee on Health Care Financing, as Required in Section 230 of Chapter 165 of the Acts of 2014 CONTENTS Executive Summary .................................................................................................................................................... 2 I. Introduction ........................................................................................................................................................ 6 II. Recommendations to Improve the Collection, Sharing, and Reporting of Behavioral Health Data ...... 7 III. Recommendations to Reduce Long Term Stays ...................................................................................... 11 A. Emergency Department .............................................................................................................. 12 B. Inpatient Psychiatric Units .......................................................................................................... 20 C. DMH Continuing Care Facilities ................................................................................................. 21 D. Outpatient Behavioral Health System ......................................................................................... 22 E. Financing the Behavioral Health System .................................................................................... 24 IV.
    [Show full text]
  • 410-396-4398 Baltimore City Health Department -White Paper- State of Health in Baltimore: Summary of Key Issues, Services and Policies Winter 2016
    Baltimore City Health Department CITY OF BALTIMORE Leana S. Wen, M.D., M.Sc. Commissioner of Health STEPHANIE RAWLINGS- 1001 E. Fayette St. BLAKE, Mayor Baltimore, MD 21202 health.baltimorecity.gov Tel: 410-396-4398 Tel: 410-396-4398 Baltimore City Health Department -White Paper- State of Health in Baltimore: Summary of Key Issues, Services and Policies Winter 2016 State of Health in Baltimore: It is impossible to discuss the health and well-being of Baltimore City’s residents without applying the lens of health equity and systemic disparities. While the overall mortality rate in Baltimore City has declined over the past decade, the City still has a mortality rate 30% higher than the rest of the state, and ranks last on key health outcomes compared to other jurisdictions in Maryland. This reality is compounded by a series of complicated systemic social, political, economic, and environmental obstacles. With more than 1 in 3 of Baltimore’s children living below the federal poverty line and more than 30% of Baltimore households earning less than $25,000/year, income, poverty, and race have enormous impact on health outcomes. This state of health is especially urgent when we consider that Baltimore houses some of the best healthcare institutions in the country. We know that healthcare alone cannot drive health: while 97% of healthcare costs are spent on medical care delivered in hospitals, only 10% of what determines life-expectancy takes place within the four walls of a clinic. Where we live, work, and play each day drives our health and well-being. As the local health authority, the Baltimore City Health Department (BCHD)’s mission is to serve Baltimore by promoting health and advocating for every individual’s well-being, in order to achieve health equity for all residents.
    [Show full text]
  • Preparing for COVID-19 Thought to Occur Mostly from Person-To-Person Via He American College Health Association Has Respiratory Droplets Among Close Contacts
    MARCH 3, 2020 ACHA Guidelines Preparing for COVID-19 thought to occur mostly from person-to-person via he American College Health Association has respiratory droplets among close contacts. Although the prepared these guidelines to help college health transmission dynamics have yet to be determined, CDC T staff and campus administrators prepare for currently recommends a cautious approach to persons coronavirus disease 2019 (COVID-19) and related issues under investigation (PUI) for COVID-19. Health care on their campuses. The guidelines are intentionally broad personnel evaluating PUI or providing care for patients so that each institution, small or large, can modify them with confirmed COVID-19 should use Standard based on existing campus and local resources. Moreover, Precautions, Contact Precautions, Airborne Precautions, each institution should seek guidance and coordination and use eye protection (e.g., goggles or a face shield). For from their local and state public health agencies. more information, see the CDC webpage “Interim Please keep in mind that the situation is rapidly evolving. Infection Prevention and Control Recommendations for Additional information about COVID-19 is available and Patients with Known or Patients Under Investigation for consistently updated from the following sources: Coronavirus Disease 2019 (COVID-19) in Healthcare U.S. Centers for Disease Control and Prevention (CDC) Settings” at https://www.cdc.gov/coronavirus/2019- www.cdc.gov/coronavirus/2019-ncov/index.html nCoV/hcp/infection-control.html. World Health Organization (WHO) While the first cases of COVID-19 seen in the U.S. were www.who.int/emergencies/diseases/novel-coronavirus-2019 associated with international travel, local transmission has been documented and more community-associated cases American College Health Association (ACHA) should be expected.
    [Show full text]
  • Kane County Health Department Begins COVID-19 Vaccines for Group 1B Essential Workers; Appointments for Seniors to Begin Within Two Weeks
    Kane County Health Department Begins COVID-19 Vaccines for Group 1B Essential Workers; Appointments for Seniors to Begin Within Two Weeks January 21, 2021 – The Kane County Health Department (KCHD) is administering COVID-19 vaccinations to an additional group of more than 1,600 Group 1A health care workers and Group 1B essential workers beginning today. “In the initial weeks of the national vaccination campaign, the supply of vaccine has been limited,” said Kane County Health Department Interim Executive Director Kathy Fosser. “We are pleased to say we are catching up on our 1A health care workers and have begun vaccinating 1B essential workers.” Healthcare workers who have not been contacted and are seeking more information about Phase 1A should contact [email protected]. Vaccine appointments for Kane County residents in priority group 1B essential workers and seniors 65 and older will begin within the next two weeks. Kane County will have more than 40 COVID-19 vaccine providers such as clinics, pharmacies, hospitals and medical practices in preparation for vaccinating group 1B. “We are committed to getting these vaccines in the arms of residents as quickly as we receive them,” said Fosser. “We anticipate our weekly allocation to increase as time goes on to allow us to more quickly get vaccine to residents.” For the Illinois Department of Public Health’s definition of Phase1A and 1B eligible personnel, please see: https://www.kanehealth.com/Pages/COVID-Vaccine.aspx. To sign up for Vaccination Information Notification bulletins, visit the Kane County Health Department website at KaneHealth.com. The public is advised to continue to take precautions.
    [Show full text]
  • Guidelines for Nurse Protocols 3 A
    GUIDELINES FOR NURSE PROTOCOLS THIS PAGE INTENTIONALLY LEFT BLANK TABLE OF CONTENTS GUIDELINES FOR NURSE PROTOCOLS 3 A. Purpose 3.1 B. Definitions 3.1 C. Drugs to be Covered by Nurse Protocol 3.2 D. Drugs to be Covered by either Nurse Protocol or 3.3 Policy/Procedure E. Requirements for a PHN Who Uses a Nurse Protocol 3.4 F. Licensed Practical Nurses 3.5 G. Requirements for Nurse Protocols 3.5 H. Delegated Authority for Ordering Dangerous Drugs 3.6 I. Dispensing Dangerous Drugs 3.6 J. Accountability 3.8 K. Signing Nurse Protocol Agreements 3.8 L. Retention of Nurse Protocols 3.14 M. Standard Nurse Protocol Agreement Formats for Advanced Practice 3.14 Registered Nurses Appendix 1 Example for Women’s Health 3.18 Appendix 2 Example for HIV 3.20 Appendix 3 Example Drug Formulary for Advanced Practice Registered Nurses 3.23 Appendix 4 Texts/References Used/Recommended for Advanced Practice 3.27 Registered Nurses THIS PAGE INTENTIONALLY LEFT BLANK Department of Public Health Nurse Protocols for Registered Professional Nurses for 2012 GUIDELINES FOR NURSE PROTOCOLS FOR REGISTERED PROFESSIONAL NURSES A. PURPOSE The purpose of these guidelines is to provide direction, promote consistency and support practice under nurse protocol by registered professional nurses in public health, in accordance with all applicable statutes, rules and regulations. B. DEFINITIONS 1. Nurse Protocol Nurse Protocol means a written document mutually agreed upon and signed by a nurse and a licensed physician, by which the physician delegates to that nurse the authority to perform certain medical acts pursuant to subsection (b) of O.C.G.A.
    [Show full text]